CRISM Therapeutics Corporation (AIM:CRTX)

CRISM Therapeutics Statistics

Total Valuation

AIM:CRTX has a market cap or net worth of GBP 3.80 million. The enterprise value is 3.45 million.

Market Cap	3.80M
Enterprise Value	3.45M

Important Dates

The last earnings date was Friday, September 19, 2025.

Earnings Date	Sep 19, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:CRTX has 39.96 million shares outstanding. The number of shares has increased by 39.18% in one year.

Current Share Class	39.96M
Shares Outstanding	39.96M
Shares Change (YoY)	+39.18%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	52.53%
Owned by Institutions (%)	3.13%
Float	17.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	151.85
PB Ratio	2.90
P/TBV Ratio	3.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.26
EV / Sales	137.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.65

Current Ratio	3.65
Quick Ratio	3.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -88.05% and return on invested capital (ROIC) is -55.03%.

Return on Equity (ROE)	-88.05%
Return on Assets (ROA)	-44.75%
Return on Invested Capital (ROIC)	-55.03%
Return on Capital Employed (ROCE)	-113.59%
Revenue Per Employee	6,250
Profits Per Employee	-381,000
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.64% in the last 52 weeks. The beta is 0.20, so AIM:CRTX's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-13.64%
50-Day Moving Average	10.31
200-Day Moving Average	11.72
Relative Strength Index (RSI)	40.54
Average Volume (20 Days)	215,437

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:CRTX had revenue of GBP 25,000 and -1.52 million in losses. Loss per share was -0.03.

Revenue	25,000
Gross Profit	18,000
Operating Income	-1.49M
Pretax Income	-1.49M
Net Income	-1.52M
EBITDA	-1.47M
EBIT	-1.49M
Loss Per Share	-0.03

Balance Sheet

The company has 349,000 in cash and n/a in debt, giving a net cash position of 349,000 or 0.01 per share.

Cash & Cash Equivalents	349,000
Total Debt	n/a
Net Cash	349,000
Net Cash Per Share	0.01
Equity (Book Value)	1.31M
Book Value Per Share	0.03
Working Capital	1.13M

Cash Flow

Operating Cash Flow	-1.33M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	72.00%
Operating Margin	-5,952.00%
Pretax Margin	-5,952.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM:CRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.18%
Shareholder Yield	n/a
Earnings Yield	-40.14%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 31, 2024. It was a reverse split with a ratio of 0.00625.

Last Split Date	May 31, 2024
Split Type	Reverse
Split Ratio	0.00625

Scores

AIM:CRTX has an Altman Z-Score of 0.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.75
Piotroski F-Score	3